BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 29329570)

  • 21. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinguishing IgG4-Related Ophthalmic Disease From Graves Orbitopathy.
    Tooley AA; Salomao DR; Bradley EA; Garrity JA
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):170-176. PubMed ID: 30124607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.
    Marinò M; Ionni I; Lanzolla G; Sframeli A; Latrofa F; Rocchi R; Marcocci C
    J Endocrinol Invest; 2020 Apr; 43(4):401-411. PubMed ID: 31691261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exophthalmos and multinodular goitre, an unusual combination.
    Okolie K; Chen D; Ghabrial R; Schmidli R
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthogranulomatous variant of immunoglobulin G4 sclerosing disease presenting as ptosis, proptosis and eyelid skin plaques.
    Mudhar HS; Bhatt R; Sandramouli S
    Int Ophthalmol; 2011 Jun; 31(3):245-8. PubMed ID: 21626164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pure eye muscle involvement in endocrine orbitopathy.
    Gerlach M; Ferbert A
    Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exophthalmos in obesity.
    Smolders MH; Graniewski-Wijnands HS; Meinders AE; Fogteloo AJ; Pijl H; de Keizer RJ
    Ophthalmic Res; 2004; 36(2):78-81. PubMed ID: 15017102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.
    Fonte R; Pirali B; Caramia V; Dionisio R; Lodigiani S; Sibilla L; Rotondi M; Chiovato L
    Thyroid; 2011 Dec; 21(12):1389-92. PubMed ID: 22066480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not All Orbitopathy Is Graves': Discussion of Cases and Review of Literature.
    Boddu N; Jumani M; Wadhwa V; Bajaj G; Faas F
    Front Endocrinol (Lausanne); 2017; 8():184. PubMed ID: 28824545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.
    Sakurai K; Inoue T; Niitsuma S; Sato R; Takahashi K; Arihara Z
    Tohoku J Exp Med; 2020 Dec; 252(4):321-327. PubMed ID: 33268601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves' Ophthalmopathy Patients.
    Luo B; Yuan X; Wang W; Zhang J; Liu R; Hu W; Qi X; Xiang N; Chen L
    Ocul Immunol Inflamm; 2022 Apr; 30(3):580-587. PubMed ID: 33054491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Interesting Case of Euthyroid Graves' Ophthalmopathy, With Negative Thyroid-Stimulating Hormone Receptor Antibodies.
    Moeen Z; Aliuddin AM; Gray Wlazlo T; Majid H; Kolli S
    Cureus; 2021 Oct; 13(10):e19015. PubMed ID: 34853745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary orbital liposarcoma misdiagnosed as thyroid associated orbitopathy.
    Shinder R; Mostafavi D; Nasser QJ; Esmaeli B; Shore JW
    Orbit; 2012 Aug; 31(4):264-6. PubMed ID: 22571512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy.
    Karhanova M; Kovar R; Frysak Z; Sin M; Zapletalova J; Rehak J; Herman M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):307-12. PubMed ID: 24510024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
    Gopinath B; Wescombe L; Nguyen B; Wall JR
    Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
    Schillings S; Wagner J; Franzen W; Wildmeister W
    Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report.
    Rau A; Klopfer M; Rommel N; Rau-Fornefeld M; Kolk A
    BMC Ophthalmol; 2018 Feb; 18(1):56. PubMed ID: 29482520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical challenge: An orbital Hickam's dictum.
    Wilson ME; Thornton S; Murchison AP; Bilyk JR
    Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.